SANTORO, ANGELA
 Distribuzione geografica
Continente #
EU - Europa 1.345
NA - Nord America 1.295
AS - Asia 658
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 2
OC - Oceania 2
Totale 3.316
Nazione #
US - Stati Uniti d'America 1.280
IE - Irlanda 464
CN - Cina 441
UA - Ucraina 337
SE - Svezia 256
TR - Turchia 85
IN - India 76
IT - Italia 64
FI - Finlandia 62
FR - Francia 57
DE - Germania 35
SG - Singapore 34
GB - Regno Unito 26
BE - Belgio 14
CZ - Repubblica Ceca 14
CA - Canada 13
ES - Italia 7
IR - Iran 7
BR - Brasile 5
EU - Europa 5
SA - Arabia Saudita 5
CL - Cile 3
JP - Giappone 3
KR - Corea 3
RU - Federazione Russa 3
AT - Austria 2
AU - Australia 2
EG - Egitto 2
MY - Malesia 2
NL - Olanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
GR - Grecia 1
IQ - Iraq 1
MX - Messico 1
NO - Norvegia 1
PA - Panama 1
PK - Pakistan 1
Totale 3.316
Città #
Dublin 464
Jacksonville 239
Chandler 224
Nyköping 169
Nanjing 152
Dearborn 132
Ann Arbor 83
Wilmington 53
Beijing 51
New York 50
Nanchang 49
Princeton 49
San Mateo 46
Ashburn 32
Shenyang 30
Jiaxing 22
Tianjin 21
Boardman 19
Changsha 16
Jinan 16
Singapore 16
Des Moines 15
Helsinki 15
Brussels 14
Hebei 14
Kunming 13
Woodbridge 13
Brno 12
Hangzhou 10
Guangzhou 8
Hilden 8
Lanzhou 6
Norwalk 6
Taizhou 6
Foggia 5
Jeddah 5
Los Angeles 5
Ottawa 5
Pune 5
Changchun 4
Ningbo 4
Seattle 4
Strasbourg 4
Auburn Hills 3
Borås 3
Granada 3
Napoli 3
Orange 3
Paris 3
Rome 3
Shanghai 3
Stevenage 3
Tehran 3
Treviso 3
Zhengzhou 3
Bisceglie 2
Cambridge 2
Campinas 2
Cedar Knolls 2
Fuzhou 2
Hanover 2
Lavagna 2
London 2
Martina Franca 2
Milan 2
Munich 2
Nola 2
Olomouc 2
Redwood City 2
San Jose 2
Shaoxing 2
Tampa 2
Turin 2
Valdivia 2
Vienna 2
Viterbo 2
Amsterdam 1
Athens 1
Augusta 1
Bangalore 1
Barletta 1
Bologna 1
Cairo 1
Canberra 1
Chongqing 1
Cornate 1
Edinburgh 1
Fiorano Modenese 1
Florence 1
Geislingen an der Steige 1
Giza 1
Hayamiya 1
Hefei 1
Houston 1
Kaigandori 1
Livorno 1
Madrid 1
Mexico 1
Mont-Laurier 1
Mumbai 1
Totale 2.216
Nome #
Immunohistochemical expression of CD3, CD20, CD45, CD68 and bcl-2 in oral squamous cell carcinoma. 152
Expression of β-catenin in human tooth germ. 109
TRAP1 regulates cell cycle and apoptosis in thyroid carcinoma cells 102
Cyclooxygenase isozymes 1 and 2 in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations 90
Epigenetic inactivation of the WNT-pathway genes in oral squamous cell carcinoma. Preliminary report 87
Report of a case of discoid lupus erythematosus localised to the oral cavity: immunofluorescence findings 85
Comparative CDH1 (E-cadherin) analysis by gene expression and epigenetic inactivation in patients affected by oral squamous cell carcinoma (OSCC). Preliminary report 85
Survivin expression in renal cell carcinoma 84
Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma 84
A Troubling Diagnosis of Verrucous Squamous Cell Carcinoma ("the Bad Kind" of Keratosis) and the Need of Clinical and Pathological Correlations: A Review of the Literature with a Case Report. 83
P16 immunohistochemistry, consensus PCR HPV-DNA, and in situ hybridization: a combined triple method to detect HPV positive oral and oropharyngeal squamous cell carcinomas 83
Expression profiling of key-genes in oral carcinogenesis. Assessment of real time PCR analysis in the context of the cancer stem cell theory 83
Epigenetic study of wnt-pathway activation in gastrointestinal cancer: validation of an epigenetic fingerprint as innovative diagnostic tool 82
Epigenetic silencing of wnt-inhibitors: activation of a constitutive wnt signalling in oral cancer 81
Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization. 78
Aurora-B kinase expression in oral squamous cell carcinoma (OSCC); a preliminary report 78
Adenocarcinoma NOS of The Maxillary Sinus: Clinical and Histopathological Features with Therapeutic Considerations 78
Overexpression of ADAR1 into the cytoplasm correlates with a better prognosis of patients with oral squamous cells carcinoma 76
OP005: Oral cancer and epigenetics: An in vitro study on 298 micro-RNA and future perspectives 73
Aberrant beta-catenin and LEF1 expression may predict the clinical outcome for patients with oropharyngeal cancer. 72
Pospho-protein-runx-2 expression is a prognostic marker of metastatic prostate carcinoma. 72
Double demonstration of oncogenic high risk human papilloma virus DNA and HPV-E7 protein in oral cancers. 71
OP094: Beta-catenin expression and its prognostic role in oral and oro-pharyngeal SCC 71
Double demonstration of oncogenic HPV DNA and HPV-E7 protein in 8.57% of oral cancers. Preliminary report 64
The role of p16 as surrogate marker of HPV in oral squamous cell carcinomas (OSCCs) cancer. Analysis by tissue micro-array (TMA), immunoistochemistry (IHC) and methylation specific PCR (MSP) 62
HPV detection in Head and Neck Cancers. The potential role of saliva 62
pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: A tissue-microarray study with clinic-pathological correlations. 62
The Role of Survivin in Thyroid Tumors: Differences of Expression in Well-Differentiated, Non–Well-Differentiated, and Anaplastic Thyroid Cancers 62
Central odontogenic fibroma of the mandible: A case report with diagnostic considerations 62
Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis 61
p-NFkB expression in thyroid cancer. 61
Detection of novel Human Papilloma virus type 82 in laryngeal cancer: case report 59
Tongue cancer and epigenetic factors: an in-vitro study on 298 micro-RNAs. 55
The role of E-cadherin down-regulation in oral cancer: Cdh1 gene expression and epigenitic blockage. 55
Epigenetic background of lauren undifferentiated gastric cancer. A methylation specific pcr analysis. 55
Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization. 54
Survivin expression in renal cell carcinoma 54
OP053. The role of sLea, sLex and CLA in oropharyngeal carcinoma: Preliminary report 54
The role of human papillomavirus in the pathogenesis of head & neck squamous cell carcinoma: an overview 53
EGFR expression, activating phosphorylations (Tyr-845 and Tyr-1068) and gene amplification in oral squamous cell carcinoma (SCC): a tissue microarray study with clinical pathological correlations 53
Epigenetic alterations in oral cancer: study of HMLH1, MGMT and RAR-beta-2 by methylation specific PCR (MSP) 53
KB-CD133 enriched cells promote tumor growth in xenograft animal models of nude mice 53
OP010: The role of epigenetic alteration in oral cancer and in oral mucosa under alcohol and cigarette smoking. A study of a panel of eleven genes by methylation specific PCR (MSP) 51
Prokineticines expression in thyroid tissues: relationship to BRAF mutation in papillary thyroid cancer 50
Upregulation of endocrine gland-derived vascular endothelial growth factor in papillary thyroid cancers displaying infiltrative patterns, lymph node metastases, and BRAF mutation 48
A possible interplay between HR-HPV and stemness in tumor development: an in vivo investigation of CD133 as a putative marker of cancer stem cell in HPV18-infected KB cell line 48
Role of β-catenin expression in paediatric mesenchymal lesions: A tissue microarray-based immunohistochemical study 43
Oral epithelial stem cells-Implications in normal development and cancer metastasis. 42
Interplay between steroid receptors and neoplastic progression in sarcoma tumors. 37
Totale 3.372
Categoria #
all - tutte 15.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.882


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020717 161 78 29 10 83 88 91 14 72 18 66 7
2020/2021377 65 5 50 3 52 16 59 13 53 57 3 1
2021/2022300 49 3 0 4 24 7 11 17 31 51 21 82
2022/20231.082 109 72 47 64 53 74 2 95 523 9 16 18
2023/2024200 33 11 4 9 13 69 14 3 1 3 7 33
2024/202516 16 0 0 0 0 0 0 0 0 0 0 0
Totale 3.372